GOSS 8-K 2026-09-28

Gossamer Bio, Inc. (GOSS) 8-K dated 2026-09-28 — accession 0001728117-26-000106. This URL is the filing, not the GOSS hub.

Gossamer Bio, Inc. (GOSS) is a biotechnology company listed on US.

Gossamer Bio, Inc. filed a 8-K on 2026-09-28. Accession 0001728117-26-000106.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.

Not investment advice. The GOSS SEC hub lists recent forms. The stock page is the research view.